1. Fascì Spurio F, Aratari A, Margagnoni G, Doddato MT, Papi C. Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid? J Gastrointestin Liver Dis. 2012. 21:67–73.
2. Kim HA, Chung SS, Kim KH, Lee RA. The change of the clinical features that Crohn's disease treated by surgery. J Korean Surg Soc. 2005. 69:135–138.
3. Lee NY, Park JH. Clinical features and course of crohn disease in children. Korean J Gastrointest Endosc. 2007. 34:193–199.
4. Kazama Y, Watanabe T, Akahane M, Yoshioka N, Ohtomo K, Nagawa H. Crohn's disease with life-threatening hemorrhage from terminal ileum: successful control by superselective arterial embolization. J Gastroenterol. 2005. 40:1155–1157.
Article
5. Alla VM, Ojili V, Gorthi J, Csordas A, Yellapu RK. Revisiting the past: intra-arterial vasopressin for severe gastrointestinal bleeding in Crohn's disease. J Crohns Colitis. 2010. 4:479–482.
Article
6. Bae JW, Ko BS, Kim DH, Jeon HJ, Park SM, Youn SC, et al. A case of Crohn's disease with blood pressure falling intestinal bleeding. Korean J Gastrointest Endosc. 1998. 18:271–275.
7. Cirocco WC, Reilly JC, Rusin LC. Life-threatening hemorrhage and exsanguination from Crohn's disease. Report of four cases. Dis Colon Rectum. 1995. 38:85–95.
8. Iiritano E, Grassia R, Staiano T, Buffoli F. Life-threatening jejunal hemorrhage as first presentation of Crohn's disease. Inflamm Bowel Dis. 2010. 16:1277–1278.
Article
9. Di Fiore F, Lecleire S, Hervé S, Savoye G, Lerebours E. Life-threatening bleeding revealing gastric involvement in a Crohn's disease patient. J Clin Gastroenterol. 2004. 38:833–834.
Article
10. Ando Y, Matsushita M, Kawamata S, Shimatani M, Fujii T, Okazaki K. Infliximab for severe gastrointestinal bleeding in Crohn's disease. Inflamm Bowel Dis. 2009. 15:483–484.
Article
11. Ye BD, Yang SK, Shin SJ, Lee KM, Jang BI, Cheon JH, et al. IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. Guidelines for the management of Crohn's disease. Korean J Gastroenterol. 2012. 59:141–179.
Article
12. Lee YJ, Oh SH, Kim KM. The principles of drug therapy of Crohn's disease in child and adolescent. Korean J Pediatr Gastroenterol Nutr. 2010. 13:Suppl 1. S59–S69.
Article
13. Gardiner KR, Dasari BV. Operative management of small bowel Crohn's disease. Surg Clin North Am. 2007. 87:587–610.
Article
14. Voitk AJ, Echave V, Feller JH, Brown RA, Gurd FN. Experience with elemental diet in the treatment of inflammatory bowel disease. Is this primary therapy? Arch Surg. 1973. 107:329–333.
Article
15. Podolny GA. Crohn's disease presenting with massive lower gastrointestinal hemorrhage. AJR Am J Roentgenol. 1978. 130:368–370.
Article
16. Barreiro de Acosta M, Seijo Ríos S, Domínguez Muñoz JE. Life-threatening acute lower gastrointestinal bleeding in patients with Crohn's disease. Rev Esp Enferm Dig. 2007. 99:388–391.
17. Suh HA, Kim SE, Jang JY, Kim BJ, Kim JS, Lee SY, et al. Efficacy of nutritional therapy in children with Crohn disease. Korean J Pediatr Gastroenterol Nutr. 2006. 9:210–217.
Article
18. Lee KM, Kim JS, Shin DH, Cheong JY, Yoo BM, Kim JK, et al. Effect of infliximab in the treatment of refractory inflammatory bowel disease with complication. Korean J Gastroenterol. 2004. 44:259–266.
19. Kim SH, Yang S, Kim KJ, Kim EH, Yoon SM, Ye BD, et al. Efficacy of infliximab in the treatment of Korean patients with crohns disease. Korean J Gastroenterol. 2009. 54:108–116.
Article
20. Ryu MK, Kim YH, Hyun JG, Moon W, Lee KS, Lee SS, et al. Clinical investigations of Crohn's disease in Korea. Korean J Med. 2001. 60:46–50.